Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024

Core Insights - Affimed N.V. will release its third quarter 2024 results and corporate update on November 14, 2024 [1] - A conference call will be held at 8:30 a.m. EST / 14:30 CET to discuss the results [1] - The conference call will be accessible via phone and webcast, with a replay available for 30 days [2][3] Company Overview - Affimed N.V. is a clinical-stage immuno-oncology company focused on enhancing patients' innate ability to combat cancer [4] - The company utilizes its proprietary ROCK® platform to develop innate cell engagers (ICE®) that target and kill various tumors [4] - Affimed is headquartered in Mannheim, Germany, and is led by a team of experienced biotechnology and pharmaceutical professionals [4] Investor Relations - The Director and Head of Investor Relations is Alexander Fudukidis, who can be contacted via email or phone for inquiries [5]